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Abstract 
Purpose: Pediatric radiotherapy requires optimal immobilization that often necessitates daily 
anesthesia. To decrease anesthesia use, we implemented a ovel XXX system which projects 
video onto a radiolucent screen within the child’s ine of vision to provide attentional 
diversion.  We investigated its reduction on anesthia use, payer charges, and treatment time, as 
well as its impact on radiation delivery. 
 
Methods and Materials: A 6-year retrospective analysis was performed among children 
undergoing radiotherapy (n=224), 3 years before and 3 after introduction of XXX.  The 
frequency of anesthesia use before and after XXX imple entation, as well as radiotherapy 
treatment times were compared.  The number of spared an sthesia treatments allowed for a 
charge to payer analysis.  To document lack of surface dose perturbation by XXX, a phantom 
craniospinal treatment course was delivered both wiand without XXX.  Additionally, an ion 
chamber course was delivered to document changes to dose at depth. 
 
Results: More children were able to avoid anesthesia use entirely in the post-XXX cohort, 
compared to the pre-XXX cohort (73.2% vs 63.4%, p=0.03) and fewer required anesthesia for 
each treatment (18.8% vs 33%; p = 0.03).  XXX introduction reduced anesthesia use for all ages 
studied.  Treatment time per session was reduced by 38% using XXX compared to 
anesthesia.  There were 326 fewer anesthesia sessions delivered over three years after XXX was 
introduced, with an estimated savings of > $500,000.  OSLDs revealed a small increase in dose 
of 0.8%-9.5% with XXX, while the use of a thermomolded face mask increased skin dose as 
much as 58%.  
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Conclusions: XXX introduction decreased anesthesia use in children undergoing radiotherapy; 
more avoided anesthesia entirely, and fewer needed it for every treatment.  This resulted in a 
reduction in treatment time, and savings of nearly $550,000 in approximately 3 years, with 




Radiation therapy is an important component of pediatric oncologic care.  Radiation requires 
optimal immobilization to precisely target the tumor while sparing normal tissues.  Highly 
conformal radiation delivery is desired in children to reduce long-term adverse effects, which 
may impact: fertility, growth, organ function, cognition, and carcinogenesis.1–3 While radiation is 
painless, it can be difficult to tolerate.  Patients must be accurately positioned and remain 
immobile during treatment sessions.  This can be challenging, as treatment sessions may take as 
long as 45+ minutes.    Hence, many pediatric patients require daily anesthesia to ensure 
immobility.  Anesthesia use is frequently required for children daily throughout their treatment 
course, which may be 4-6 weeks.   
 
Administration of daily anesthesia may carry short and long-term risks and is associated with 
high healthcare costs. Patients undergoing general anesthesia at a young age have increased risk 
of hypoxia, acute allergic reactions, and hyperthermia.4  Animal models have demonstrated an 
association between general anesthesia and long-term n urocognitive deficits including neuronal 
apoptosis, reduced cognitive function, and prolonged b havioral consequences.5,6  A recent 
report described an association between anesthesia exposure and detrimental neurocognitive and 
neuroimaging changes in survivors of childhood acute leukemia.7  Neurocognitive impairment 
was associated with cumulative propofol dose, flurane exposure, and cumulative duration of 
anesthesia time.  Additionally, slower processing speed and imaging changes were associated 
with these factors.7 Multiple reports advocate for limited use of general anesthetics.8,9 Notably, 
the U.S. Food and Drug Administration (FDA) recently issued a warning on the negative impact 
of repeated use of general anesthesia on brain developm nt in children.10  
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Daily administration of anesthesia requires an anesthesiologist, specific time allocation on the 
radiotherapy schedule, careful coordination between th  radiation oncologist and 
anesthesiologist, and additional preparation – all increasing radiotherapy treatment time. 
Anesthesia also places a burden on healthcare charges; anesthesia for a 6-week course of 
radiation therapy has been quoted to equal approximately $50,000 in payer charges.11 Given the 
risks and additional burden this places on pediatric patients and healthcare staff, it is necessary to 
reduce anesthesia use whenever possible.  
 
Watching videos can decrease anxiety in children during various hospital procedures.12–14  We 
hypothesized that watching videos during radiotherapy would translate to better tolerance of 
daily radiotherapy without anesthesia.  Thus, we developed and tested a novel audio-visual 
assisted therapeutic ambience in radiotherapy (XXX) system to enable children to watch videos 
during radiation.  In an initial pilot study, XXX use was described in 25 patients of whom 23 
(92%) completed a course of treatment without anesthesia, indicating promise for further 
investigation.15 Here we describe our 6-year experience, analyzing the impact of XXX among 
112 pediatric patients during the three years after its implementation, as compared to 112 
controls during the three years prior to its implementation.  We investigated XXX’s effectiveness 




Methods and Materials 
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System Design 
The XXX system is a novel technology enabling children to watch videos during radiation 
treatment delivery.15  The system mounts a portable projector to the treatm nt table cephalad to 
the patient’s head and displays streaming wireless video on a custom radiolucent screen (Figure 
1). Allowing the radiation beam to pass through the screen with minimal degradation, minimal 
scatter, and minimal effect on the electronic operation of the video playback were critical design 
considerations. 
 
For routine clinical use, we have improved our system from that reported in our pilot study.  For 
setup flexibility we use tripod links combined with a 3D printed telescoping mount (Figure 1).  
The screen is attached to the links by carbon fiberstrips which provide sufficient flexibility and 
strength to withstand potential gantry collisions.  The system can be mounted at a single point, or 
the projector and the screen can be mounted separatly.  Additionally, we have added a louder 
speaker, a keystone correcting projector, and a webcam.  The screen is constructed from 0.25mm 
thick matte plastic sheet supported by hollow 3D printed plastic arms with maximum water 
equivalent thickness of 2mm.  The screen is curved to avoid potential interference with gantry 
rotation, and located approximately 15 cm above the patient’s head.  The telescopic mount 
allows the screen to pivot and adjust, facilitating customizable viewing while lying supine, and is 
comfortably in view even when wearing a face mask.  The screen is constructed from low atomic 
number plastics and is thin to minimally attenuate the beam. Dosimetric analyses were 
performed to verify minimal changes in dose delivery. 
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Each XXX system costs approximately $500, including materials for the mounting system plus 
the video tablet.  Our institution only required one system.  Initial commissioning and setup of 
the XXX system requires roughly one hour.  It takes approximately 1-2 minutes to setup per 
treatment.     
 
Patient Characteristics and Anesthesia Use  
We introduced the XXX system in September of 2015.  Following Internal Review Board 
approval, we reviewed all children treated with radiation since the introduction of XXX between 
September 2015 and December 2018 (n=112) and compared them to an equal sized cohort of 
children treated prior to XXX (February 2012 to August 2015, n=112). Patients 3-12 years were 
included in the analysis, as all children 0-2 years required anesthesia, and none greater than 12 
years did.  The XXX system was made available to any patient who needed, or preferred, its use 
to assist with immobilization and comfort during treatment. All patients were candidates for 
XXX, unless they absolutely required anesthesia.  25 out of 112 patients did not require either 
anesthesia or XXX.    Comparisons were made between the two cohorts overall, as well as within 
the following age categories: 3-4, 5-7, and 8-12 years.   
 
Treatment Time Calculations 
Treatment times were calculated for each individual session as the interval from when radiation 
therapists first open a patient’s encounter when thy bring them to the treatment room, to when 
radiation delivery is complete.  2470 treatment sessions since introduction of XXX were 
analyzed, and treatment times were compared between sessions delivered with anesthesia, 
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sessions delivered with XXX, or sessions delivered with neither.  TBI patients were excluded as 
there was no standard documentation of treatment time.  
Dosimetric Measurements 
A CSI radiation course was delivered onto an Alderson RANDO phantom (Radiology Support 
Devices, Long Beach, CA).  The delivered dose was measured using optically stimulated 
luminescent dosimeters (OSLDs, Landauer, Glenwood, IL) at 6 different locations: the forehead, 
left and right lens, maxilla, chin, and anterior neck.  Three sessions of treatment were delivered 
to the phantom from which averages and standard deviations were calculated.  Dosimetric data 
were collected using an earlier version of the radiolucent screen that was used by the majority of 
patients in this study and was three to five times greater in radiological thickness than our 
updated screen.  To discern whether the dose perturbation was within a clinically acceptable 
range, treatment was delivered in three settings: with the phantom alone, with a thermoplastic 
mask in place, and with the thermoplastic mask plusXXX.   
 
Additional dose measurements were run with the use of the XXX system and a Markus A10 
parallel plate ion chamber (Best Medical, Nashville, TN) placed in a rectangular water-
equivalent plastic phantom. This allowed measurements of both dose at surface as well as a 5cm 
depth.  The surface of the ion chamber was placed on the central axis of the beam at 100 cm 
from the linac source. A 6 MV, 200 monitor unit hemispherical arc was delivered onto the 
phantom.  Measurements were made with and without the XXX screen in place.  
 
 
Payer Charges Calculations 
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A 6 week/30 session course of anesthesia for radiation treatment costs $50,000 in payer charges, 
equating to $1667 per session. 11  We used this data to perform a savings analysis since XXX 
implementation.  The number of anesthesia sessions avoided was calculated by obtaining the 
difference in anesthesia sessions prior to and after XXX use.  From this we calculated the 
charges avoided in our XXX cohort over the time period September 2015-December 2018.   
 
Statistical Analysis 
In order to compare patients treated before and after in roduction of XXX, T tests were used for 
continuous outcomes such as treatment volume and weight loss.  Chi-square tests were used for 
categorical outcomes such as anesthesia use (yes/no).  
 
To calculate odds ratios of anesthesia use, data was an lyzed in a multi-variable logistic 
regression model at the patient level.  The model controlled for: age, ECOG, treatment category 
(head/neck/brain, torso/extremities, CSI, TBI), useof pain medication, and recent surgery.  
Variables that were tested and had no impact on the model were excluded. 
 
In order to compare treatment time between anesthesia and XXX system, a mixed effects model 
was used to account for within patient correlation between treatment sessions.  Treatment 
volume, ECOG, age, and recent surgery were also included in the model.  This outcome was 
analyzed for the whole cohort as well as for only those treated after the introduction of XXX. All 
tests performed were two-sided with an alpha level of 0.05. All analyses were performed using 
SAS v 9.4 (SAS Institute Inc., Cary, NC, USA).     
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Results   
Patient Characteristics 
Patients treated pre-XXX introduction and post-XXX introduction were well matched by: 
gender, age, treatment region, pain medication, anxiety medication, cancelled treatments, and 
treatment fractions (Table 1).  The mean age of patients treated post-XXX introduction was 7.5 
years while those treated pre-XXX was 7.6 years (p=0.76).  There was no difference in total 
treatment sessions per patient between the two groups (p=0.55).  Additionally, there was no 
increase in cancellations or treatment extensions in patients treated after the introduction of XXX 
(p=0.17).  There were significant differences between the two cohorts in terms of treatment 
volume (the post-XXX introduction cohort had larger treatment volumes), performance status, 
and recent surgery.  These variables were controlled for in our multivariable model.  As 
expected, there was greater use of child-life servic s n the patients treated post-XXX 
introduction to support the system’s implementation.   
 
Decreased Anesthesia Use  
We assessed whether XXX introduction resulted in decreased anesthesia use.   
 
There were two patient measures of anesthesia usage: 1. Patients who required any anesthesia 
use during their treatment course, and 2. Patients who successfully avoided anesthesia entirely, 
or only required anesthesia at the beginning of their course but then transitioned off (these 
patients were designated as “successes”).   
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More patients treated after XXX was introduced were able to avoid anesthesia, as compared to 
those treated prior to XXX introduction (73.2% vs 63.4% p=0.03) (Figure 2). On multivariable 
logistic regression analysis, the patients treated pr -XXX introduction had 3.04 times the odds of 
needing anesthesia during at least one treatment session, as compared to those treated post-XXX 
introduction (95% CI 1.19-7.78).  
   
There were more “successes” in patients treated aftr XXX introduction - as compared to the 
patients treated pre-XXX (81.2 % vs 67%, p=0.015).  On multivariable logistic regression 
analysis, post-XXX patients had 7 times the odds of not needing anesthesia or successfully 
transitioning off anesthesia (95% CI 2.56-19.15).  
 
A total of 4,375 treatment sessions were delivered between the two patient cohorts.  There were 
fewer sessions requiring anesthesia among those treat d post-XXX introduction (494 sessions 
over three years, 22.1%) as compared to those treated pre-XXX introduction (820 sessions over 
three years, or 38.3%, p=<0.0001).  Older age was associated with less anesthesia use; each 
additional year of age had 0.38 times the odds of anesthesia use (95% CI 0.29-0.50).  However, 
even as patients age, XXX continues to reduce anesthesia use.   We found decreased anesthesia 
use in every age category within those treated post-XXX introduction: age 3-4, 61.4% of 
sessions required anesthesia versus 88.4% in the cohort treated prior to XXX (p <0.0001); age 5-
7, 35% of sessions required anesthesia versus 56% in those treated pre-XXX (p <0.0001); of 
those ages 8-12 years, no sessions of treatment required anesthesia after introduction of XXX 
(0%) versus 13% in the patients treated before introduction of XXX (p <0.0001) (Figure 3).   
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Shorter Treatment Time  
There was significantly longer treatment time for sessions delivered with anesthesia versus those 
with the XXX system (p <0.0001). Average treatment time per session was 36.7 minutes with 
anesthesia, 22.6 minutes with XXX, and 20.3 minutes with neither. 
 
Sessions delivered with the XXX system were 38% shorter than sessions with anesthesia, saving 
14 minutes per treatment (p<0.0001).  There was no ignificant difference between sessions 
delivered with the XXX system and those delivered without it, indicating it is not a significant 
time burden to add the XXX system onto treatments (p=0.4).   
 
Impact on Dosimetry 
Analysis of any change in delivered surface dose to the head and neck area with the XXX system 
in place was compared to changes using a thermoplastic f ce mask alone.  Both the mask and the 
XXX system resulted in an increase in delivered surface dose. However, the mask gave a 
substantially greater increase in dose than did the XXX system in all measured areas except the 
lens of the eye.  XXX demonstrated an average increased surface dose of 0.8% to 9.5% 
depending on the treatment site: 0.8% (SD 5%) to the forehead, and 9.5% (SD 5%) to the lens.  
By comparison, the thermoplastic mask resulted in an increased dose from 2% to 58% depending 
on the treatment site: 2% (SD 5.2%) to the anterior neck, and 58% (SD 9.17%) to the forehead.   
 
The ion chamber measurements analyzed any changes for dose at depth, and revealed 4.6% 
excess surface dose with the XXX system in place, and a 0.7% dose reduction at 5 cm depth. The 
uncertainty in these measurements was 0.2%. 
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Payer Charge Savings 
There were 820 sessions delivered with anesthesia in p t ents treated pre-XXX introduction, 
versus 494 sessions delivered with anesthesia in those treated post-XXX introduction. Thus, 
there was an avoidance of 326 anesthesia sessions after XXX was introduced.  This equates to a 
projected savings of $543,333.00 in payer charges.  
 
Discussion 
XXX is a novel system allowing children to watch video on a radiolucent screen during 
radiotherapy, diverting their attention during treament, and providing increased comfort so as to 
successfully complete radiotherapy without the need for anesthesia.  In this report we 
demonstrate a significant decrease in anesthesia use during pediatric radiotherapy after 
introducing the XXX system.  This decrease was seen both in the number of children who 
required anesthesia, and the total number of treatmnt sessions that required anesthesia.  
 
Previous work documented frequent anesthesia use in children undergoing radiation with rates as 
high as 100% for those <3 years, over 90% for those ages 3-5, and 45-70% for those ages 6-7.16 
Frequent anesthesia use carries concerns: long-term adverse effects, complexity of delivering 
anesthesia in an outpatient radiation department, prolonged treatment time, and increased 
charges to payer and patient.   
 
Given the frequent anesthesia use for pediatric radiotherapy, it is important to understand its 
consequences.  These include neurocognitive dysfunction, prompting the FDA to issue warnings 
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about repeated anesthesia use causing potential brain damage.  Most recently, Banerjee et al 
found increased risk of neurocognitive impairment with increased anesthesia exposure  in 
survivors of pediatric leukemia..  Additionally, propofol exposure and total anesthesia time 
demonstrate higher white matter mean diffusivity in the corpus collosum, which correlates with 
decreased processing speed.7 
 
There have been other proposed strategies to reduce anesthesia use in pediatric radiation therapy, 
including psychoeducation intervention, child life specialists, and even mounted television 
screens that are stationary and located outside the radiation beam.11,17–19 Most of these 
interventions have shown some success, with the child life specialist decreasing anesthesia use in 
children ages 3-12 from 57% to 40.8%,11 however these methods have shortcomings and require 
hiring and training specialists to coordinate schedul s, and the use of an inflexible TV mount  
that cannot be manipulated between patients.  
 
By design, XXX is simple and customizable from patien  to patient, does not require additional 
personnel, and has been highly successful.  After XXX introduction, <20% of children needed 
anesthesia for their full treatment course, while prior to XXX it was 33%.  Seventy-three percent 
of our patients ages 3-12 were able to avoid anesthesia entirely after XXX introduction, while 
before only 64% did so.  The ability for a child and family to go through an entire treatment 
course without requiring daily anesthesia improves quality of life.   
 
Any reduction in anesthesia use is of clinical signif cance.   We observed a 16% reduction in 
treatment sessions requiring anesthesia after XXX was introduced, and it was useful in each age 
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group investigated.  It was beneficial in the young children (ages 3-4), where most children still 
required some anesthesia, but 17% fewer sessions required it with XXX.  It was also greatly 
beneficial in older children (8-12) where no session of treatment required anesthesia in those 
treated post-XXX introduction, entirely negating dependence on anesthesia in this age group.  
 
Further, our finding that XXX reduces treatment time by approximately 15 minutes leads to 
several opportunities.  Children and their parents can return from the radiation department and 
back to their lives substantially sooner each day.  In the cases where patients transitioned off 
anesthesia, parents have noted a reduction in stress on their children in preparing for daily visits 
to the clinic. While our results demonstrate decreased treatment machine time, there is also 
important time savings from not having to check in for daily anesthesia nor recovery from 
anesthesia care.  Furthermore, decreasing treatment i e by half potentially allows radiation 
departments additional treatment time periods for other patients.   
 
Given treatment is delivered with the XXX radiolucent screen in the line of the beam, there are 
inherent concerns about its impact on radiation dosimetry.  Our measurements using a phantom 
did demonstrate a small increase in radiation surface dose, and a small decrease in dose at depth.  
The maximum increase in dose was measured on the lens of each eye and was <10% of the 
planned dose to the lens.  It is notable though that the change in dose is less than that from the 
thermoplastic face mask which is used regularly during pediatric treatment.  The decrease in 
dose measured at a 5cm depth with the XXX system in place was <1%.The XXX system assists 
with immobilization, but on balance there are small dosimetric consequences.   
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Monetary savings in health care are highly relevant in the current healthcare landscape. .  
Previous studies have demonstrated a 30-session treatment course is charged to the payer as 
$50,000 (accounting for both the anesthetic medications as well as the medical professional 
fees).  Given that we found a 40% decrease in sessions delivered with anesthesia after the 
introduction of XXX, over a three-year period, this translates to over half a million dollars saved 
in payer charges.  This does not account for decreased payer charges from the PACU recovery 
time.  There are additional departmental savings due to decreased treatment time and ability to 
get additional patients on the machines.   
 
We acknowledge limitations of our study, including ts retrospective nature.  There are only 
limited scenarios when the XXX system would be contrai dicated, such as orbit or optic 
pathway tumors where treatment relies on minimizing eye movement.  This system has not yet 
been studied with proton therapy.  However, if treatment was designed so that incoming beams 
only passed through the 0.2mm screen, we would project minimal disturbance of the proton 
beam.  Our departmental data only captures treatment times, but does not capture total time 
associated with daily treatment including time to che k in for anesthesia, and the time for 
anesthesia recovery.  Finally given the charges analysis utilizes national means and previously 
reported values, it is an early analysis, and future work could involve analysis of cost savings due 
to decreased time on the machine and additional patient throughput.   
 
To our knowledge, we report the first pilot program of this device allowing streaming video 
through which a radiation beam can pass, is mounted to the treatment table and customized for 
optimal viewing patient to patient.  There are numerous future potential uses for this device, 
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including streaming more interactive content such as video feed with family, or utilizing the 
system for other patients struggling with immobility such as adults suffering from pain or 
anxiety.  To further delineate the benefits of the XXX system, there is a currently 
enrolling multi-institutional clinical trial prospectively examining the effects of XXX on 
anesthesia avoidance and outcomes among pediatric pients (NCTXXXXXXXX). 
 
Conclusions 
XXX is a novel system allowing children to watch video during treatment, which both helps 
distraction and immobilization.  Introducing the XX system decreases anesthesia use in 
children undergoing radiotherapy; more children are abl  to avoid anesthesia entirely, and fewer 
need anesthesia for every treatment.  XXX reduces an thesia use for all ages.  Treatment time is 
reduced by over one-third with XXX when compared to anesthesia.  Additionally, use of the 
XXX resulted in an estimated savings of nearly $550,00  in approximately 3 years.  These 
benefits come with minimal dose perturbation.  XXX is currently being studied in an ongoing 
prospective multicenter trial (NCTXXXXXXXX).    
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Figure 1: Updated XXX System. Audiovisual system design projects videos while patient lies 
supine.  The system, including a pico-projector, speaker, and screen, mounts to the head of the 
treatment table.  An adjustable arm positions the screen display in the patient’s field of view 
while avoiding collision with the treatment machine. Video and sound are transmitted 
wirelessly and power is provided by a rechargeable battery. 
 
 
Figure 2. Decreased Anesthesia Use Between XXX Cohort and Pre-XXX Cohort. Use of 
anesthesia comparing patients who were treated using the XXX system, and those who were 
treated before XXX implementation.  There is a significant difference in the percentage of 
patients who were able to avoid anesthesia entirely, and those who were able to transition off 
of anesthesia amongst the XXX cohort vs the pre-XXX group.  
 
 
Figure 3. Increased Number of Treatment Sessions Performed Without Anesthesia in the XXX 
Cohort vs Pre-XXX Cohort. Anesthesia use in patients using XXX compared to those without XXX 
according to age group. Patients using XXX had significantly more treatment sessions without 
anesthesia in each age group 
 
 
Table 1. Baseline Characteristics of XXX Cohort Compared to Pre-XXX Cohort 
Characteristic Pre-XXX (%) 
n = 112 
XXX (%) 
n = 112 
p value 
Gender   0.42 
Female 47 (42) 53 (47) 
Male 65 (58) 59 (53) 
Age    0.76 
     Mean (years) 7.63 7.52 
     Categories   0.85 
3-4 19 (17) 18 (16) 
5-7 41 (37) 37 (33) 
>7 53 (47) 56 (50) 
Treatment Volume  
(mean cm3)a 
842.8 1171.8 0.03 
Treatment Region   0.13 
     Brain/Head/Neck 41 (37) 34 (30) 
     Torso 26 (23) 35 (31) 
     Extremity 9 (8) 2 (2) 
     CSI* 17 (15) 22 (20) 
     TBI* 19 (17) 19 (17) 
ECOG    0.02 
     0 21 (19) 44 (39) 
     1 70 (63) 48 (43) 
     2 13 (12) 13 (12) 
     3 5 (4) 4 (4) 
     4 3 (3) 3 (3) 
Recent Surgeryb 31 (28) 18 (16) 0.04 
Pain Medicationc 36 (32) 44 (39) 0.26 
Anxiety Medicationd 21 (19) 21 (19) 1.00 
Child-life Servicese 54 (48) 81 (72) 0.0002 
Cancelled Treatments   0.17 
     0 87 (78) 95 (85) 
     1 14 (13) 11 (10) 
     ≥2 11 (10) 6 (5) 
     Patients with any       
     cancelled treatments 
25 (22) 17 (15) 
Treatment Fractions    0.55 
Total 2142  2233 
Mean, per patient 19.1 19.9 
     Categories   0.33 
0-10 23 (21) 29 (26) 
11-20 38 (34) 26 (23) 
21-30 41 (37) 44 (39) 
>30 10 (9) 13 (12) 
Fractions with 
Anesthesia 
  <0.001 
Anesthesia  820    (38) 494    (22) 
No anesthesia 1,322 (62) 1,739 (78) 
 
a
Treatment volumes calculated for patients with 3D or IMRT plans and did not include electron plans or TBI.  There 
were 91 treatment volumes included in the pre-XXX cohort and 93 treatment volumes in the XXX cohort 
b
Recent surgery defined as within 30 days of radiation start 
c
Any pain medication, standing or PRN, at the start of radiation  
d
Any anxiolytics, standing or PRN, at the start of radiation 
e
Use of Child-Life services anytime during the course of radiation 
*Abbreviations: Craniospinal irradiation (CSI), total body irradiation (TBI) 
Comparison of characteristics between the pre-XXX and post-XXX cohorts.  Importantly, 
fractions delivered to patients using anesthesia significantly differed between each cohort. 
 
Figure 2. Decreased Anesthesia Use Between Post-XXX Cohort and Pre-XXX Cohort 
 
Use of anesthesia in comparing patients who were treated while using the XXX system, and those who 
were treated before XXX implementation . There is a significant difference in the percentage of patients 
who were able to avoid anesthesia entirely, and those who were able to transition off of anesthesia 




Figure 3. Increased Number of Treatment Sessions Performed Without Anesthesia in the XXX Cohort 




Anesthesia use in patients using XXX compared to those without XXX according to age group. Patients 
using XXX had significantly more treatment sessions without anesthesia in each age group  
Figure 1: Updated XXX System  
 
Audiovisual system design projects videos while patient lies supine.  The system, including a pico-
projector, speaker, and screen, mounts to the head of the treatment table.  An adjustable arm positions 
the screen display in the patient’s field of view while avoiding collision with the treatment machine. 
Video and sound are transmitted wirelessly and power is provided by a rechargeable battery. 
 
